Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ESMO 2016 /
Advances for NSCLC in review

7th - 11th Oct 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 09.10.16
Views: 1832

Dr Stefan Zimmermann - Hôpital Fribourgeois, Fribourg, Switzerland

Dr Stefan Zimmerman speaks with ecancertv at ESMO 2016 to summarise newly reported advances in lung cancer.

He comments on the press conference presentations of Dr Giorgio Scagliotti, Dr Martin Reck, Dr Fabrice Barlesi and Dr Corey Langer who spoke about different immunologic and cell cycle therapies improving progression free survival and overall survival of patients.

ecancer's filming at ESMO 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation